TOOLGEN INCORPORATED
17Patents
16Active
17Granted
49Portfolio score
Filing activity: Sep 24, 2003 → Dec 28, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10851380B2 | Methods for cleaving a target DNA using a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein | Chemistry; Metallurgy | 34 | Active |
| US7514257B2 | Zinc finger transcription factor differentiation proteins | Chemistry; Metallurgy | 20 | Expired |
| US9809839B2 | Method for concentrating cells that are genetically altered by nucleases | Physics | 1 | Active |
| US10519454B2 | Genome editing using Campylobacter jejuni CRISPR/CAS system-derived RGEN | Chemistry; Metallurgy | 1 | Active |
| US12241071B2 | Composition for editing flavonoid biosynthetic gene by using CRISPR/Cas9 system, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12163149B2 | Artificial genome manipulation for gene expression regulation | Chemistry; Metallurgy | 0 | Active |
| US12275963B2 | Artificially manipulated immune cell | Emerging Cross-Sectional Technologies | 0 | Active |
| US11920151B2 | Method for identifying DNA base editing by means of cytosine deaminase | Chemistry; Metallurgy | 0 | Active |
| US12331086B2 | Artificially engineered SC function control system | Chemistry; Metallurgy | 0 | Active |
| US12286635B2 | Oleic acid-enriched plant body having genetically modified FAD2 and production method thereof | Chemistry; Metallurgy | 0 | Active |
| US11845951B2 | Gene manipulation for treatment of retinal dysfunction disorder | Emerging Cross-Sectional Technologies | 0 | Active |
| US11441135B2 | Target-specific CRISPR mutant | Chemistry; Metallurgy | 0 | Active |
| US11572574B2 | Artificial genome manipulation for gene expression regulation | Chemistry; Metallurgy | 0 | Active |
| US11667934B2 | Platform for expressing protein of interest in liver | Chemistry; Metallurgy | 0 | Active |
| US12012598B2 | Manipulated immunoregulatory element and immunity altered thereby | Emerging Cross-Sectional Technologies | 0 | Active |
| US11999952B2 | Artificially-manipulated neovascularization regulatory system | Emerging Cross-Sectional Technologies | 0 | Active |
| US12351838B2 | Target-specific CRISPR mutant | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.